Skip to main content

Advertisement

Table 1 Clinical features at the first ultrasound examination of the skin of 75 SSc patients

From: High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study

Features Median (IQR)
Age (years) 52.4 (44.8–62.0)
Disease duration (months) 10.9 (7.9–19.1)
mRSS 10.5 (4.0–19)
Serum-COMP (U/L) 12 (10–17) (n = 62)
HAMIS 6.0 (3.5–14) (n = 54)
  n (%)
Women 62 (83)
lcSSc 42 (56)
Immunosuppressive treatment (yes/no)a 39/36 (52/48)
  1. mRSS modified Rodnan skin score, COMP cartilage oligomeric matrix protein, HAMIS hand mobility in scleroderma test, lcSSc limited cutaneous systemic sclerosis, dcSSc diffuse cutaneous systemic sclerosis
  2. aCyclophosphamide (n = 16); Azathioprine (n = 10); Methotrexate (n = 7); Mycophenylate mofetil (n = 12). Six patients received two different treatments during the first year of follow-up